0001567619-21-020867.txt : 20211119
0001567619-21-020867.hdr.sgml : 20211119
20211119172021
ACCESSION NUMBER: 0001567619-21-020867
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210107
FILED AS OF DATE: 20211119
DATE AS OF CHANGE: 20211119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jooss Karin
CENTRAL INDEX KEY: 0001754280
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38663
FILM NUMBER: 211429386
MAIL ADDRESS:
STREET 1: C/O GRITSTONE ONCOLOGY, INC.
STREET 2: 5858 HORTON STREET, SUITE 210
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Gritstone bio, Inc.
CENTRAL INDEX KEY: 0001656634
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5959 HORTON STREET, SUITE 300
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: (510) 871-6100
MAIL ADDRESS:
STREET 1: 5959 HORTON STREET, SUITE 300
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: Gritstone Oncology, Inc.
DATE OF NAME CHANGE: 20151023
4
1
doc1.xml
FORM 4
X0306
4
2021-01-07
0
0001656634
Gritstone bio, Inc.
GRTS
0001754280
Jooss Karin
C/O GRITSTONE BIO, INC.
5959 HORTON STREET, SUITE 300
EMERYVILLE
CA
94608
0
1
0
0
See Remarks
Common Stock
2021-01-07
4
A
0
27900
0
A
349784
D
Represents Restricted Stock Units ("RSUs") which vest in two equal annual installments over a two year period measured from the grant date. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.
Includes 27,900 RSUs which are subject to vesting.
Executive Vice President and Chief Scientific Officer
/s/ Rahsaan Thompson, Attorney-in-Fact for Karin Jooss
2021-11-19